Kim H B, Shaaban A F, Yang E Y, Liechty K W, Flake A W
Department of Surgery, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, 19104, USA.
J Surg Res. 1998 Jun;77(1):1-5. doi: 10.1006/jsre.1997.5255.
Donor-specific tolerance has been induced after both fetal and neonatal hematopoietic stem cell (HSC) transplantation in mice. However, the relationship between hematopoietic microchimerism and tolerance in these models has not been defined due to the insensitivity of donor cell detection methodology. To address this problem we developed a semiquantitative polymerase chain reaction (PCR)-based assay for detection of microchimerism after major histocompatibility (MHC) class I disparate HSC transplantation. This assay was used to examine the relationship between microchimerism and tolerance after fetal and neonatal transplantation of fully allogeneic bone marrow cells.
C57BL/6 mice (H2-Kb) were used as adult bone marrow donors and Balb/c mice (H2-Kd) were used as fetal or newborn recipients. A dose of 10(10) BM cells/kg was injected intraperitoneally into recipient animals. Peripheral blood of animals which survived beyond 3 weeks of age was analyzed by PCR for the presence of donor MHC class I DNA. Tolerance was tested by placement of donor-specific skin grafts after determination of chimerism status.
Our assay was found to be specific for H2-Kb donor cells in an H2-Kd background with a sensitivity of <0.0001%. Of 49 animals injected in utero 19 (38%) had donor DNA present in peripheral blood at low levels (<0.1%) whereas only 1 of 18 neonatally injected animals had detectable donor cells (P < 0.01). Tolerance to donor-specific skin grafts was found in 6 of 9 animals which were chimeric after in utero HSC transplantation whereas none of the 18 neonatally injected animals including the chimeric animal were tolerant.
Our results indicate the following. (
在小鼠的胎儿和新生儿造血干细胞(HSC)移植后均已诱导出供体特异性耐受。然而,由于供体细胞检测方法的不敏感性,这些模型中造血微嵌合体与耐受之间的关系尚未明确。为了解决这个问题,我们开发了一种基于半定量聚合酶链反应(PCR)的检测方法,用于检测主要组织相容性复合体(MHC)I类不相合的HSC移植后的微嵌合体。该检测方法用于研究全同种异体骨髓细胞在胎儿和新生儿移植后微嵌合体与耐受之间的关系。
将C57BL/6小鼠(H2-Kb)用作成年骨髓供体,将Balb/c小鼠(H2-Kd)用作胎儿或新生儿受体。以10(10)个骨髓细胞/千克的剂量腹腔注射到受体动物体内。对存活超过3周龄的动物的外周血进行PCR分析,以检测供体MHC I类DNA的存在。在确定嵌合状态后,通过植入供体特异性皮肤移植物来测试耐受情况。
我们发现该检测方法对H2-Kd背景中的H2-Kb供体细胞具有特异性,灵敏度<0.0001%。在49只子宫内注射的动物中,19只(38%)外周血中存在低水平(<0.1%)的供体DNA,而18只新生儿期注射的动物中只有1只检测到供体细胞(P<0.01)。在9只子宫内HSC移植后嵌合的动物中,有6只对供体特异性皮肤移植物产生耐受,而18只新生儿期注射的动物(包括嵌合动物)均无耐受。
我们的结果表明:(1)子宫内注射全同种异体HSC后,可通过PCR在外周血中检测到造血微嵌合体。(2)胎儿注射产生微嵌合体的发生率高于新生儿注射。(3)子宫内HSC移植可诱导跨越全同种异体屏障的耐受,这与外周血微嵌合体的存在有关。